TrialClinical and experimental nephrology2024

Oral alkalinizing supplementation suppressed intrarenal reactive oxidative stress in mild-stage chronic kidney disease: a randomized cohort study.

Michiaki Abe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.